NorthWest Biotherapeutics Inc (NWBO)

[CherryTree1]

Thanks for posting this PGSD.

AI Overview
New MHRA/NICE Collaboration - Pharmacy Consulting
The main difference is that the MHRA (Medicines and Healthcare products Regulatory Agency) is responsible for authorizing medicines and devices for sale in the UK based on safety and effectiveness, while NICE (National Institute for Health and Care Excellence) evaluates whether those medicines are a good value for money for the NHS. The MHRA's role is regulatory, ensuring the product is safe and works, whereas NICE's role is advisory, assessing clinical and cost-effectiveness to recommend if it should be used on the NHS.
Medicines and Healthcare products Regulatory Agency (MHRA)
Role: The MHRA grants marketing authorizations for medicines and medical devices.
Focus: It ensures that products are safe, high-quality, and effective.
Authority: It is an executive agency of the Department of Health and Social Care.
National Institute for Health and Care Excellence (NICE)
Role: NICE provides guidance on the clinical and cost-effectiveness of new drugs and technologies.
Focus: It evaluates whether a medicine offers good value for the money spent by the NHS.
Authority: It is an executive non-departmental public body of the Department of Health and Social Care.
How they work together
Historically, NICE would issue guidance after the MHRA had already authorized a product.
The two organizations now have initiatives to work more closely, including pilot programs for concurrent reviews, to speed up patient access to new medicines by making decisions on safety and value at the same time.
This new, aligned approach aims to reduce the time it takes for new treatments to become available to patients on the NHS